Ondra Health press
Press releases, company facts and media contact information for Ondra Health, a Los Angeles–based telehealth platform for GLP-1 weight management.
Quick answer
Ondra Health is a LegitScript-certified telehealth platform based in Los Angeles. It offers compounded semaglutide and tirzepatide through independent licensed providers and names its partner pharmacies publicly. Ondra Health announced its launch on May 27, 2026. For media inquiries, email care@ondra.health.
At a glance
Company facts
Ondra Health Inc., an independently owned telehealth company founded in 2026 and based in Los Angeles, California.
Online GLP-1 weight management with compounded semaglutide and tirzepatide, prescribed by independent licensed providers when appropriate.
Wasef Health, PC and Arora Health & Aesthetics, LLC, independent medical practices.
Named partner pharmacies, listed with state availability on our Pharmacy Partners page.
Compounded semaglutide is $149 a month and compounded tirzepatide is $219 a month on monthly plans, the same at every dose, with lower monthly prices on longer plans. No membership fee.
LegitScript certified. HIPAA compliant.
Depends on your state. See our Service Areas page.
Newest first
Press releases
Ondra Health Expands to Six Named GLP-1 Pharmacy Partners, Giving Patients More Choice
Ondra Health announced an expanded network of named partner pharmacies for compounded semaglutide and tirzepatide, citing positive patient feedback about choosing a pharmacy.
Read on GlobeNewswire →Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
Ondra Health published its 2026 GLP-1 Treatment and Pharmacy Guide, naming the licensed compounding pharmacies that fill its prescriptions, the prescribing medical group and its prices.
Read on GlobeNewswire →Millions of Americans Still Haven't Started GLP-1 Treatment. Here's Why.
A look at why many people interested in GLP-1 treatment haven't started yet, including cost, uncertainty and mixed information, and how Ondra Health approaches those concerns.
Read on openPR →Ondra Health Launches Nationwide, Making GLP-1 Weight Loss Treatment More Transparent and Accessible
Ondra Health announced its launch as a telehealth platform for GLP-1 weight management, built around upfront pricing and a choice of licensed partner pharmacies.
Read on Business Wire →Press releases are shown as originally published. Some details have changed since, including prices, plan options and pharmacy partners. For current details, see our semaglutide and tirzepatide pages and our Pharmacy Partners page.
Contact
Media and patient resources
Media inquiries
For interviews, company information or comment. We aim to reply within 24 hours.
Patient reviews
Read what patients say about Ondra Health on Google and Trustpilot, and the themes that come up most.
Ondra Health is a telehealth platform. Medical services are provided by independent licensed providers, who decide whether treatment is appropriate. Compounded semaglutide and tirzepatide are not FDA-approved and are not therapeutically equivalent to Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Press releases were distributed through the wire services named above. Brand names are trademarks of their respective owners.